抗体效价(log2) U: m$ e- R1 w
| 攻毒数 , f/ T" p E# a$ g: G
| 死亡数
; {& }. G( L! C% v; G) p | 存活数
3 w' i2 @/ V* ^8 i, \+ D3 P | 保护率%
& i J& q5 P& z9 Z; H; ` |
0" R& E1 z' h' H- f8 n
| 6/ D3 ~- P; D; S+ g: r' \
| 6
; u- ]! @ h3 p | 05 S l! C5 ~$ O7 ]- C& @9 k: |
| 0
, {, Q" F5 c* l. ]% g1 n' T3 U |
1
' L! u, l+ h- ~0 Y4 {0 X' O | 60 n& ^2 B$ @7 g. J/ c5 J
| 6
' }' A6 J) |, y& |8 n! E5 Y | 03 z" [# X+ U4 T" [5 ^. K
| 0/ T2 {- K& }3 O+ J x8 N: {
|
2 5 l. \' p1 O1 ?5 L1 h* r
| 6
' J n5 U* C9 R | 3 + z7 t n" g. ~" ~1 v5 C9 w
| 3
6 n. c) X7 n0 f4 `* M, \4 x | 50 2 a( o) ]7 Z$ g# Y/ t
|
3
) z4 a% r Z2 u& ] | 6 ' r0 D, M$ \$ f4 J/ r! ?4 n: [7 ^
| 0 $ w5 i& m6 u" C5 H
| 6 , h6 B5 Y8 t) C! c( K* p
| 100 ; Q$ X1 t% X, z1 q# X" y- @% m2 r3 ^
|
4
7 W7 z: O2 f: g | 6 ?8 U$ ]0 O$ w2 Z: A
| 0 6 T6 j& k+ }5 H# a
| 6
/ h& z5 V5 w# Q8 x; g" x | 100
& Y' O* ?) p; U9 `- z# f |
# b7 B; S1 K+ v! p日龄" X/ S& C$ a0 g1 _7 y! [( z
|
" |& ^/ s7 D9 Z$ }( ?. g免疫后
6 A; ^3 @9 D& l! d1 g- m |
1周 4 K; l! g x, c6 z H
| 2周 : O( o* z/ X; M$ W$ X2 J
| 3周
1 X$ z% S. q" H4 j8 k% Q | 4周
! `0 B! S# {% d | 5周 7 v ?4 ?8 y$ |2 P0 ~# j3 G) {
| 6周 % ]: B( K3 }+ ^. Q
| 7周 ) G3 N" _3 {3 P6 v% z9 q% l
| 8周 ! ], P2 j; X7 {; G+ l
|
300 R$ w, r3 j7 v5 a0 x
| 1.67±0.58c
4 u& Y6 n% c7 P$ S | 2.75±0.96bc9 S; p7 x. S3 c5 z* }4 J: E
| 1.75±0.96b- o8 V1 @* ^, Q8 n
| 1.00±0.00d
2 b: s8 ]& r! @# J6 G9 W | 0.25±0.50c
! F' Y! f3 g1 j8 t, y( n | 0.13±0.25c7 T/ H) s; c' R7 K- D3 l" D, w* q M
| 0
5 H; _ L1 F# P; e2 ? | 0/ F) P! K( S9 E6 Q7 I* o. U l5 M
|
35
D/ `0 q- W" @5 m6 i9 I | 3.25±0.50ab) }* P9 n& K8 X) M. J; `5 c5 u
| 3.00±0.82bc
) R& I) H$ W/ R4 ~$ U- i* g5 v | 2.38±0.49b
8 O; }1 t0 y- J) s1 _ | 2.00±0.00c& w0 l; E K8 {9 ]
| 1.00±0.00c
$ ^9 k5 z& U4 J; \- @, y | 0.75±0.50c6 S, t8 C& ?; Z y. t' C
| 03 H4 u; a, t. f2 P9 w# n" c1 P
| 0
7 i. ~" M5 I- A! Z w [ |
408 d0 Q: P) {& n1 g/ ^
| 3.00±0.82ab) P E/ u W& D- _5 R3 a( j
| 5.75±1.71a
' k- \. l, o' j8 n, }! H4 J | 5.00±1.83a
F- K, ~. G. t+ Y | 3.25±1.50b, v, ?+ D) V2 L+ E
| 3.00±0.82b! Q* V" A6 U- e6 J* _* B# [
| 2.13±0.50b
7 o o4 ?. |( z' q) U7 D | 1.83±0.58bc7 a: g5 |7 K! h4 p6 B* j
| 1.03±0.63bc
7 v% m, ?/ K+ l |
454 D- j' W" ?- h F; O
| 3.25±1.26ab) @# y' l- T g+ @& p8 P+ z
| 4.25±0.96ab
! U; S9 h# t, I5 S a | 5.50±1.29a+ K* I1 Z6 U# `( x( D" K y; i
| 3.75±0.96b3 F- B9 `) c( i4 e, L
| 3.25±1.26b
& d/ g4 k! q' [* X | 2.38±1.80b
! m! k0 h& z2 G4 ? | 2.00±1.41bc
2 p- f* \6 m9 l r1 Q' W: c7 D | 1.13±0.63bc3 \1 c2 R7 W7 K/ _7 z9 O, w. P
|
507 L5 p; j4 k7 ]
| 2.25±0.50bc
2 B4 S$ c% c6 O" B: d1 z% I0 V; E | 4.25±0.96ab
7 a r" ]7 |( c( c8 o | 4.50±2.08a
# ^- f% A8 E/ J* G( E; ` | 5.75±0.50a2 U6 o9 H. Y0 S! G
| 6.00±0.00a, }; M ]% ?5 ~9 b) B7 j5 k
| 5.00±0.00a
8 E* q6 a) K7 g- L4 z& b; g9 t5 `3 i# C | 3.5±0.58ab; O" w" x3 o1 u( s9 _6 s5 w
| 1.50±0.58b
4 P3 b7 W, ]. f I |
55
3 z8 L- k8 {7 m' w | 3.50±0.58a! @7 h- q& M } O' w
| 4.75±0.50a
- r8 a4 j q/ \; `9 s4 n9 c4 u, k | 6.00±0.82b
! T) Y! J) K+ m8 W- ?% M | 5.75±1.50a
! {3 d* i% d* D- B1 N% F# o4 T | 5.25±0.96a
/ A/ z7 i" K4 e( J& Y: N2 V | 4.25±0.50a$ V/ U& o/ v8 y( q$ E
| 3.25±0.96b* e4 |3 G6 @( a* S5 {
| 2.75±1.26ab: P! x4 o5 T9 H0 S/ B5 N
|
60: }! D9 D: n G3 g0 K! j; O* e
| 3.50±0.58a3 J1 C2 a1 Y8 i5 M- h& k5 l
| 5.00±0.82a+ r! o1 O# c$ D$ }1 H7 v
| 6.25±0.50a M2 z* ?) ~2 C
| 5.75±0.96a; ^5 T0 i. N7 E+ Q C: ]
| 5.00±0.82a/ K4 B% D* M7 V/ N4 ^! O+ A
| 4.13±0.85a4 J0 R, i/ L4 a" E6 {. H
| 3.25±0.96b/ h8 S) ~) S4 G* j- V& q
| 2.25±0.96b& X2 Q5 ~( n8 j a
|